Teyi Pharmaceutical Group Co.,Ltd

Shenzhen Stock Exchange 002728.SZ

Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -14.85 M

Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities is USD -14.85 M for the year ending December 31, 2023, a -1.30% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -14.66 M, a 73.89% change year over year.
Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -56.14 M, a -292.80% change year over year.
Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -14.29 M, a -702.46% change year over year.
Teyi Pharmaceutical Group Co.,Ltd Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 2.37 M, a 312.63% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shenzhen Stock Exchange: 002728.SZ

Teyi Pharmaceutical Group Co.,Ltd

CEO	Mr. Songqing Xu
IPO Date	July 31, 2014
Location	China
Headquarters	No. 9, 11, Changxing Road
Employees	1,243
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.

Key trends

Past 5 years